Guidance and best practices for long-term maintenance with medications for patients with Opioid Use Disorder (OUD) from the OASAS Medical Advisory Panel.
Preliminary guidance for reopening Opioid Treatment Program (OTP) services on a regional basis amid New York Forward and the evolving COVID-19 pandemic. (updated document 4/14/21)
Drug Enforcement Administration guidance allowing for more flexibility for practitioners to prescribe buprenorphine to new and existing patients with OUD via telephone during the nationwide public health emergency...
Patients may now be initiated on buprenorphine through the use of telepractice in accordance with DEA guidance that is in effect during the state of emergency.
OASAS guidance on the administration and dispensing of narcotic medications to treat opioid use disorders including information on the Data 2000 waiver.
